LIFEMED (LMED3) Main Indicators
Basic Data - LMED3
| Company | LIFEMED |
| Corporate Name | LIFEMED INDUSTRIAL EQUIP. DE ART. MÉD. HOSP. S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Bovespa Mais |
| Activity | Fabricação de instrumentos não eletronicos e utensilios para uso médico. odontológico e de laboratório; |
| Share | LMED3 |
| Quote Date | NA |
| Share Type | ON |
| Last Closing | NA |
| Quotation Factor | NA |
| Financial Volume | NA |
| Last Statement | ITR - 06/30/2024 |
| Sector | Saúde |
| Subsector | Equipamentos |
| Segment | Equipamentos |
| Participation Indexes | - |
| Updated 11/10/2024 | |
Relative Prices - LMED3
| Price/Earnings | 0.00 |
| Price/SBV | 0.00 |
| Price/Net Sales | 0.00 |
| Price/CFO | 0.00 |
| Price/FCF | 0.00 |
| Price/Total Assets | 0.00 |
| Price/EBIT | 0.00 |
| Price/Working Capital | 0.00 |
| Price/NCAV | 0.00 |
| EV/EBIT | NA |
| EV/EBITDA | NA |
| EV/Net Sales | NA |
| EV/CFO | NA |
| EV/FCF | NA |
| EV/Total Assets | NA |
| Company Market Cap | NA |
| Enterprise Value | NA |
| Current Financial Statement Date | 06/30/2024 |
| Current Share Price | R$ 0.00 |
| Share Price Date | //0 |
| Dividend Yield | 0.00% |
| Updated 11/09/2024 | |
Income Statement - LMED3
| Net Revenue | R$ 96.80 M |
| Gross Result | R$ 45.58 M |
| EBIT | R$ 6.88 M |
| Depreciation and Amortization | - R$ 14.58 M |
| EBITDA | R$ 21.46 M |
| Net Profit | - R$ 20.43 M |
| Net Profit/Share | - R$ 3.96 |
| Updated 08/14/2024 | |
| Net Revenue | R$ 26.32 M |
| Gross Result | R$ 11.53 M |
| EBIT | - R$ 4.02 M |
| Depreciation and Amortization | - R$ 3.57 M |
| EBITDA | - R$ 447.00 thousand |
| Net Profit | - R$ 9.26 M |
| Profit/Share | - R$ 1.80 |
| Updated 08/14/2024 | |
Price and Volume Behavior - LMED3
There are no quotes for this ticker.
Returns and Margins - LMED3
| Return on Initial Tangible Capital | 1.49% |
| Return on Initial Invested Capital | 1.48% |
| Pre-Tax Return on Initial Tangible Capital | 2.26% |
| Pre-Tax Return on Initial Invested Capital | 2.24% |
| Return on Initial Shareholder´s Equity | -11.94% |
| Return on Initial Asset | -5.49% |
| Gross Margin | 47.09% |
| Net Margin | -21.10% |
| EBIT Margin | 7.11% |
| EBITDA Margin | 22.17% |
| Initial Asset Turnover | 0.26 |
| Financial Leverage | 2.07 |
| Liabilities/Net Worth | 1.07 |
| Net Debt/EBITDA | 3.88 |
| Updated 08/14/2024 | |
Balance Sheet - LMED3
| Cash and Cash Equivalents | R$ 119.00 thousand |
| Total Assets | R$ 312.60 M |
| Short-Term Debt | R$ 12.42 M |
| Long-Term Debt | R$ 71.00 M |
| Gross Debt | R$ 83.42 M |
| Net Debt | R$ 83.30 M |
| Shareholder´s Equity | R$ 151.26 M |
| Share Book Value | R$ 29.35 |
| Common Shares | 2,576,438 |
| Preferred Shares | 2,576,438 |
| Total | 5,152,876 |
| Common Shares in Treasury | 0 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 0 |
| Common Shares (Except Treasury) | 2,576,438 |
| Preferred Shares (Except Treasury) | 2,576,438 |
| Total (Except Treasury) | 5,152,876 |
| Updated 08/14/2024 | |
Cash Flow - LMED3
| Operating Cash Flow | R$ 106.96 M |
| Cash Flow from Investments | - R$ 31.15 M |
| Financing Cash Flow | - R$ 77.09 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 1.28 M |
| Updated 08/14/2024 | |
| Operating Cash Flow | R$ 6.35 M |
| Cash Flow from Investments | - R$ 7.93 M |
| Financing Cash Flow | R$ 1.22 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 366.00 thousand |
| Updated 08/14/2024 | |
Experimental - LMED3
| CAPEX 3 months | - R$ 7.74 M |
| Free Cash Flow 3 months | - R$ 1.39 M |
| CAPEX 12 months | - R$ 29.76 M |
| Free Cash Flow 12 months | R$ 77.20 M |
| Updated 08/14/2024 | |
Quote Chart - LMED3
There are no quotes for this ticker.